Table of Contents

company-logo

HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transplantation from cytomegalovirus-positive donors. Its lead oncology product candidates are HB-201 and HB-202 that are in Phase I/II clinical trial for the treatment of human papillomavirus 16-positive cancers. The company's preclinical stage products include HB-300 program for prostate cancer; and HB-700 for targeting mutated KRAS in pancreatic, colorectal, and lung cancer. HOOKIPA Pharma Inc. has a collaboration with Gilead Sciences, Inc. to collaborate on preclinical research programs to evaluate potential vaccine products using or incorporating its replicating and non-replicating technology platforms for the treatment, cure, diagnosis, or prevention of Hepatitis B Virus. The company was incorporated in 2011 and is headquartered in New York, New York.

HOOKIPA Pharma Dividend Announcement

• HOOKIPA Pharma does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on HOOKIPA Pharma dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

HOOKIPA Pharma Dividend History

HOOKIPA Pharma Dividend Yield

HOOKIPA Pharma current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing HOOKIPA Pharma stock? Use our calculator to estimate your expected dividend yield:

HOOKIPA Pharma Financial Ratios

P/E ratio-0.95
PEG ratio-0.01
P/B ratio0.54
ROE-51.77%
Payout ratio0.00%
Current ratio3.86
Quick ratio3.86
Cash Ratio2.77

HOOKIPA Pharma Dividend FAQ

Does HOOKIPA Pharma stock pay dividends?
HOOKIPA Pharma does not currently pay dividends to its shareholders.
Has HOOKIPA Pharma ever paid a dividend?
No, HOOKIPA Pharma has no a history of paying dividends to its shareholders. HOOKIPA Pharma is not known for its dividend payments.
Why doesn't HOOKIPA Pharma pay dividends?
There are several potential reasons why HOOKIPA Pharma would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will HOOKIPA Pharma ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While HOOKIPA Pharma has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is HOOKIPA Pharma a dividend aristocrat?
HOOKIPA Pharma is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is HOOKIPA Pharma a dividend king?
HOOKIPA Pharma is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is HOOKIPA Pharma a dividend stock?
No, HOOKIPA Pharma is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy HOOKIPA Pharma stocks?
To buy HOOKIPA Pharma you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy HOOKIPA Pharma stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.